Genzyme biopharmaceuticals news

Genzyme said that it is making headcount reductions and will provide additional details this week. In May, Genzyme announced plans to reduce costs and pursue strategic alternatives for three of its businesses. Genzyme has 12,800 employees. At June 30, the company had $834.5 million in cash and a six month operating loss of $173.6 million (see BioCentury, May 10). ...